Stock 2877 CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

China Shineway Pharmaceutical Group Limited Stock

Equities

2877

KYG2110P1000

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:12 2024-06-14 am EDT 		5-day change 1st Jan Change
7.98 HKD +1.27% Intraday chart for China Shineway Pharmaceutical Group Limited -4.20% +9.77%
Mar. 28 China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 08 China Shineway Pharmaceutical to Log Higher Profit in 2023; Shares Up 3% MT

Financials

Sales 2024 * 5.24B 722M 5.64B Sales 2025 * 6.06B 835M 6.52B Capitalization 5.6B 772M 6.03B
Net income 2024 * 1.13B 156M 1.22B Net income 2025 * 1.31B 180M 1.41B EV / Sales 2024 * -0.04 x
Net cash position 2024 * 5.82B 802M 6.27B Net cash position 2025 * 6.3B 869M 6.79B EV / Sales 2025 * -0.12 x
P/E ratio 2024 *
5.1 x
P/E ratio 2025 *
4.41 x
Employees 3,436
Yield 2024 *
7.65%
Yield 2025 *
8.94%
Free-Float 33.69%
More Fundamentals * Assessed data

Chart China Shineway Pharmaceutical Group Limited

Dynamic Chart

Latest news about China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Shineway Pharmaceutical to Log Higher Profit in 2023; Shares Up 3% MT
China Shineway Pharmaceutical Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
​​China Shineway Pharmaceutical Logs 22% Rise in Q1-Q3 Turnover MT
China Shineway Pharmaceutical Group Limited Announces Resignation of Executive Director CI
China Shineway Pharmaceutical Group Limited Announces Resignation of Liu Tiejun as Executive Director, Effective 1 November 2023 CI
China Shineway Pharmaceutical’s Profit Rises 48% in H1 MT
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China BlueChemical, Unit to Invest in Structured Deposit Products MT
China Shineway Pharmaceutical’s H1 Profit to Rise By Up to 50% MT
China Shineway Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 CI
Bank of China Raises 30 Billion Yuan with Bond Issue MT
Shineway Pharmaceutical's Q1 Turnover Rises 36% MT
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
China Shineway Pharmaceutical Group Limited Announces Board Changes CI
More news

Press releases China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical : Shineway (2877.HK) Q1 revenue increased by 37.0% AQ
China Shineway Pharmaceutical : TURNOVER FOR THE FIRST QUARTER OF 2021 PU
China Shineway Pharmaceutical : Form of proxy for use at the annual general meeting to be held on Friday, 28 May 2021 (or at any adjournment thereof) PU
China Shineway Pharmaceutical : Proposals for General Mandates to Repurchase Shares and to issue shares, Re-election of Retiring Directors, Declaration of Final Dividend and Notice of Annual General Meeting PU
China Shineway Pharmaceutical : records 29.4% revenue growth in October AQ
More press releases

Quotes and Performance

1 day+1.27%
1 week-4.20%
Current month-4.55%
1 month-18.15%
3 months-16.53%
6 months+14.00%
Current year+9.77%
More quotes

Highs and lows

1 week
7.78
Extreme 7.78
8.25
1 month
7.78
Extreme 7.78
9.90
Current year
7.22
Extreme 7.22
10.72
1 year
6.55
Extreme 6.55
10.72
3 years
4.63
Extreme 4.63
10.72
5 years
4.60
Extreme 4.6
10.72
10 years
4.60
Extreme 4.6
18.54
More quotes

Managers and Directors - China Shineway Pharmaceutical Group Limited

Managers TitleAgeSince
Zhen Jiang Li FOU
 Founder 68 02-08-13
King Kuen Hung IRC
 Investor Relations Contact 58 -
Baochang Liu SAM
 Sales & Marketing 44 19-11-30
Members of the board TitleAgeSince
Zhen Jiang Li FOU
 Founder 68 02-08-13
Wencheng Zhou BRD
 Director/Board Member 48 20-09-30
Yun Xia Xin FOU
 Founder 60 02-08-13
More insiders

ETFs positioned on China Shineway Pharmaceutical Group Limited

Name Weight AuM 1st Jan change Investor Rating
SIMPLIFY EMERGING MARKETS PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Emerging Markets Plus Downside Convexity ETF - USD
0.01% 4 M€ -4.41% -
LEADERSHARES EQUITY SKEW ETF - USD ETF LeaderShares Equity Skew ETF - USD
0.00% 114 M€ +4.32% -
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 32 M€ +3.87% -
More ETFs positioned on China Shineway Pharmaceutical Group Limited

Quotes

Date Price Change Volume
24-06-14 7.98 +1.27% 591,000
24-06-13 7.88 -1.25% 647,000
24-06-12 7.98 -0.99% 1,401,000
24-06-11 8.06 -2.07% 1,390,000
24-06-07 8.23 -1.20% 329,000

Delayed Quote Hong Kong S.E., June 14, 2024 at 04:08 am EDT

More quotes

Company Profile

China Shineway Pharmaceutical Group Limited is an investment holding company principally engaged in the research and development, manufacture and trading of modern Chinese medicines. Its main products include injections, soft capsules and granules. The Company’s subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.
Sector
Pharmaceuticals
Calendar
2024-08-29 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for China Shineway Pharmaceutical Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.412 CNY
Average target price
13.03 CNY
Spread / Average Target
+75.86%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED Stock China Shineway Pharmaceutical Group Limited
+9.77% 762M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.37% 43.39B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+19.44% 22.01B
SANDOZ GROUP AG Stock Sandoz Group AG
+17.85% 15.46B
CIPLA LIMITED Stock Cipla Limited
+25.55% 14.93B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+60.99% 13.13B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-15.02% 6.36B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.17% 5.43B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 2877 Stock